Benitec Biopharma (BNTC) Retained Earnings (2019 - 2025)
Historic Retained Earnings for Benitec Biopharma (BNTC) over the last 7 years, with Q1 2025 value amounting to -$219.4 million.
- Benitec Biopharma's Retained Earnings fell 1863.02% to -$219.4 million in Q1 2025 from the same period last year, while for Mar 2025 it was -$219.4 million, marking a year-over-year decrease of 1863.02%. This contributed to the annual value of -$190.3 million for FY2024, which is 1332.43% down from last year.
- Benitec Biopharma's Retained Earnings amounted to -$219.4 million in Q1 2025, which was down 1863.02% from -$204.9 million recorded in Q4 2024.
- Over the past 5 years, Benitec Biopharma's Retained Earnings peaked at -$126.1 million during Q1 2021, and registered a low of -$219.4 million during Q1 2025.
- Over the past 5 years, Benitec Biopharma's median Retained Earnings value was -$163.2 million (recorded in 2023), while the average stood at -$165.6 million.
- Its Retained Earnings has fluctuated over the past 5 years, first crashed by 1155.99% in 2021, then plummeted by 1863.02% in 2025.
- Benitec Biopharma's Retained Earnings (Quarter) stood at -$140.0 million in 2021, then fell by 13.46% to -$158.8 million in 2022, then fell by 13.73% to -$180.6 million in 2023, then dropped by 13.41% to -$204.9 million in 2024, then fell by 7.08% to -$219.4 million in 2025.
- Its Retained Earnings was -$219.4 million in Q1 2025, compared to -$204.9 million in Q4 2024 and -$195.3 million in Q3 2024.